scholarly journals Tumour-homing chimeric polypeptide-conjugated polypyrrole nanoparticles for imaging-guided synergistic photothermal and chemical therapy of cancer

Theranostics ◽  
2018 ◽  
Vol 8 (10) ◽  
pp. 2634-2645 ◽  
Author(s):  
Mengmeng Sun ◽  
Jianwen Guo ◽  
Hanjun Hao ◽  
Tong Tong ◽  
Kun Wang ◽  
...  
Molecules ◽  
2021 ◽  
Vol 26 (12) ◽  
pp. 3607
Author(s):  
Olena Dobrovolska ◽  
Øyvind Strømland ◽  
Ørjan Sele Handegård ◽  
Martin Jakubec ◽  
Morten L. Govasli ◽  
...  

The driving forces and conformational pathways leading to amphitropic protein-membrane binding and in some cases also to protein misfolding and aggregation is the subject of intensive research. In this study, a chimeric polypeptide, A-Cage-C, derived from α-Lactalbumin is investigated with the aim of elucidating conformational changes promoting interaction with bilayers. From previous studies, it is known that A-Cage-C causes membrane leakages associated with the sporadic formation of amorphous aggregates on solid-supported bilayers. Here we express and purify double-labelled A-Cage-C and prepare partially deuterated bicelles as a membrane mimicking system. We investigate A-Cage-C in the presence and absence of these bicelles at non-binding (pH 7.0) and binding (pH 4.5) conditions. Using in silico analyses, NMR, conformational clustering, and Molecular Dynamics, we provide tentative insights into the conformations of bound and unbound A-Cage-C. The conformation of each state is dynamic and samples a large amount of overlapping conformational space. We identify one of the clusters as likely representing the binding conformation and conclude tentatively that the unfolding around the central W23 segment and its reorientation may be necessary for full intercalation at binding conditions (pH 4.5). We also see evidence for an overall elongation of A-Cage-C in the presence of model bilayers.


Biomaterials ◽  
2004 ◽  
Vol 25 (13) ◽  
pp. 2477-2488 ◽  
Author(s):  
Guixin Shi ◽  
Mahmoud Rouabhia ◽  
Zhaoxu Wang ◽  
Lê H Dao ◽  
Ze Zhang

2010 ◽  
Vol 57 (1) ◽  
pp. 17-24 ◽  
Author(s):  
Yang Wang ◽  
Zhongqiang Guo ◽  
Qing Ge ◽  
Enhua Wang ◽  
Xiuli Zhang ◽  
...  
Keyword(s):  

Author(s):  
VS. .. Karavaev ◽  
E. S. Oleinikova ◽  
M. Sh. Azaev ◽  
A. B. Beklemishev'

Aim. Comparative study of antigenic properties of recombinant proteins OspCgar and OspCafz and recombinant chimeric polypeptide OspCgar+afZ, that contains amino acid sequences of mature immune dominant OspC proteins of West-Siberian isolates of Borrelia garinii (OspCgar) and B. afzelii (OspCafz), and evaluation of possibility of their use as antigens during creation of test-systems for serodiagnostics of Lyme borreliosis (LB) on the territory of Western Siberia. Materials and methods. Recombinant chimeric polypeptide OspCgar+afz and recombinant mature proteins OspCgar and OspCafz, obtained by expression of the corresponding genes in Escherichia coli cells, purified by affinity chromatography in Ni-NTA-sepharose CL-6B and studied by EIA method for the ability to bind antibodies from sera of LB patients. Results. A difference in sensitivity of determination by EIA method of specific IgM and IgG against borreliae in blood sera of LB patients with localized stage of the disease during use of OspCgar, OspCafz and OspCgar+afZ chimera as antigens was shown. Chimeric antigen OspCgar+afz was established to show higher antigenic activity compared with each of the OspCgar or OspCafZ antigens separately. Conclusion. The results of the study allow to examine the recombinant chimeric polypeptide OspCgar+afz as a possible component during creation of test-systems for serodiagnostics of LB on the territory of West Siberia.


Biomaterials ◽  
2017 ◽  
Vol 143 ◽  
pp. 130-141 ◽  
Author(s):  
Xuejun Wang ◽  
Haichun Li ◽  
Xianping Liu ◽  
Ye Tian ◽  
Huishu Guo ◽  
...  

Nanoscale ◽  
2018 ◽  
Vol 10 (20) ◽  
pp. 9773-9779 ◽  
Author(s):  
Devleena Samanta ◽  
Niloufar Hosseini-Nassab ◽  
Aidan D. McCarty ◽  
Richard N. Zare

Redox-active anti-cancer drugs can be released without compromising their bioactivity from polypyrrole nanoparticles that respond to ultra-low voltages (−75 mV).


Sign in / Sign up

Export Citation Format

Share Document